291
Participants
Start Date
February 11, 2020
Primary Completion Date
May 22, 2023
Study Completion Date
February 28, 2026
Selpercatinib
Administered orally
Cabozantinib
Administered orally
Vandetanib
Administered orally
Royal North Shore Hospital, St Leonards
The Alfred Hospital, Melbourne
Peter MacCallum Cancer Centre, Melbourne
Seoul National University Hospital, Seoul
Severance Hospital, Yonsei University Health System, Seoul
Centre Hospitalier Universitaire de Liège - Domaine Universitaire du Sart Tilman, Liège
Sir Charles Gairdner Hospital, Perth
Samsung Medical Center, Seoul
Hospital Universitari Vall d'Hebron, Barcelona
Instituto Catalan de Oncologia - Hospital Duran i Reynals, L'Hospitalet de Llobregat
Memorial Sloan Kettering Cancer Center, New York
Charité Universitaetsmedizin Berlin - Campus Mitte, Berlin
Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Turin
National Cancer Center, Goyang-si
Seoul National University Bundang Hospital, Seongnam
Assistance Publique Hôpitaux de Marseille - Hôpital Nord, Marseille
Centre François Baclesse, Caen
Institut Català d'Oncologia (ICO) - Girona, Girona
University of Pennsylvania Hospital, Philadelphia
Thomas Jefferson University, Philadelphia
Istituto Auxologico Italiano, Milan
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
Hämato-Onkologie Hamburg, Prof. Laack und Partner, Hamburg
Centre Georges François Leclerc, Dijon
Hospital General Universitario Gregorio Marañon, Madrid
Clinica Universidad de Navarra, Madrid
Hospital Universitario Ramón y Cajal, Madrid
Hospital Clinico San Carlos, Madrid
Hospital Universitario 12 de Octubre, Madrid
Hospital Universitario La Paz, Madrid
Chungbuk National University Hospital, Jungbuk
Hospital Universitario Virgen de la Victoria, Málaga
Emory University, Atlanta
Medizinische Hochschule Hannover, Hanover
Clinica Universidad de Navarra, Pamplona
Institut Claudius Regaud, Toulouse
Institut Bergonié - Centre Régional de Lutte Contre Le Cancer de Bordeaux et Sud Ouest, Bordeaux
Istituto Oncologico Veneto IRCCS, Padua
University of Alabama at Birmingham, Birmingham
Otto-von-Guericke-Universität Magdeburg, Magdeburg
The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center, Columbus
Universitaetsklinikum Essen, Essen
University of Cincinnati Medical Center, Cincinnati
University of Michigan, Ann Arbor
Centre Hospitalier Universitaire d'Angers, Angers
Hospital Universitario Miguel Servet, Zaragoza
Ospedale Le Scotte, Siena
University of Wisconsin Hospitals and Clinics, Madison
Universitätsmedizin Johannes Gutenberg Universität Mainz, Mainz
Azienda Ospedaliera Universitaria Pisana, Pisa
Hopital Claude Huriez - CHU de Lille, Lille
University of Chicago Medical Center, Chicago
Centre Jean Perrin - Centre Régional de Lutte contre le Cancer d'Auvergne, Clermont-Ferrand
Centre Paul Strauss, Strasbourg
Centre Leon Berard, Lyon
Pitie Salpetriere University Hospital, Paris
University of Texas MD Anderson Cancer Center, Houston
University of Naples Federico II, Napoli
Klinikum der Universität München Großhadern, München
UCLA Hematology/Oncology - Westwood (Building 100), Los Angeles
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance
Gustave Roussy, Villejuif
Azienda Ospedaliera Garibaldi, Catania
University of California Davis (UC Davis) Comprehensive Cancer Center, Sacramento
Klinikum der Universität München Großhadern, Würzburg
Beijing Tongren Hospital affiliated to Capital Medical University, Beijing
"Fed State Budgetary Inst N.N. Blokhin Med Center of Oncology MHRF", Moscow
Endocrinology Research Center of Rosmedtechnologies, Moscow
Jilin Cancer Hospital, Changchun
Harbin Medical University Cancer Hospital, Harbin
Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh
Saint Petersburg State University, Saint Petersburg
Saint-Petersburg City Clinical Oncology Dispensary, Saint Petersburg
Fudan University Shanghai Cancer Center, Shanghai
Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School, Nanjing
Anhui Provincial Hospital, Hefei
A. Tsyb Medical Radiological Research Center - branch of the National Medical Research Radiological, Obninsk
Jinan Central Hospital, Jinan
Tianjin Medical University Cancer Institute and Hospital, Tianjin
Zhejiang Provincial People's Hospital, Hangzhou
Sir Run Run Shaw Hospital, Hangzhou
Zhejiang Cancer Hospital, Hangzhou
The First Affiliated Hospital Of Fujian Medical University, Fuzhou
Chongqing University Cancer Hospital, Chongqing
Hunan Cancer Hospital, Changsha
Grant Medical Foundation - Ruby Hall Clinic, Pune
Deenanath Mangeshkar Hospital & Research Centre, Pune
HCG Manavata Cancer Centre, Nashik
Henan Cancer Hospital, Zhengzhou
Clinic Evimed, Chelyabinsk
Sun Yat-Sen University Cancer Centre, Guangzhou
West China Hospital, Sichuan University, Chengdu
First Affiliated Hospital of Kunming Medical University, Kunming
Regional Cancer Centre - Thiruvananthapuram, Thiruvananthapuram
Apollo Gleneagles Hospitals Kolkata, Kolkata
Gansu Cancer Hospital, Lanzhou
Rabin Medical Center, Petah Tikva
Sheba Medical Center, Ramat Gan
Hadassah Medical Center, Jerusalem
Fundação Pio XII - Hospital de Câncer de Barretos, Barretos
City of Hope National Medical Center, Duarte
Massachusetts General Hospital, Boston
Oncocentro, Belo Horizonte
Hospital de Cancer de Londrina, Londrina
Hospital de Clinicas de Porto Alegre, Porto Alegre
Centro de Pesquisa Sao Lucas, Campinas
Hospital de Clínicas de Ribeirão Preto, Ribeirão Preto
Hospital Sírio Libanês, São Paulo
Instituto D'Or de Pesquisa e Ensino (IDOR), São Paulo
Instituto Nacional de Câncer - INCA, Rio de Janeiro
Grupo Oncoclínicas Botafogo, Rio de Janeiro
Grupo COI - Clínicas Oncológicas Integradas, Rio de Janeiro
Icesp - Instituto Do Câncer Do Estado de São Paulo, São Paulo
Centro Paulista de Oncologia Clínica, São Paulo
Princess Margaret Cancer Centre, Toronto
Fakultní nemocnice Brno Bohunice, Brno
Fakultni nemocnice Motol, Prague
Fakultni nemocnice Olomouc, Olomouc
Alexandra Hospital, Athens
University General Hospital of Heraklion, Heraklion
European Interbalkan Medical Center, Thessaloniki
Policlinico Umberto I, Rome
Istituto Nazionale Tumori Regina Elena, Rome
Aichi Cancer Center Hospital, Nagoya
National Cancer Center Hospital East, Kashiwa
Hokkaido University Hospital, Sapporo
Kobe University Hospital, Kobe
Yokohama City University Hospital, Yokohama
Osaka University Hospital, Suita
Japanese Foundation for Cancer Research, Koto
National Hospital Organization Kyushu Medical Center, Fukuoka
Maastricht UMC+, Maastricht
Nederlands Kanker Instituut - Antoni van Leeuwenhoek (NKI-AVL), Amsterdam
Leids Universitair Medisch Centrum, Leiden
University Medical Center Groningen, Groningen
Narodowy Instytut Onkologii - Oddzial w Gliwicach, Gliwice
Swietokrzyskie Centrum Onkologii, Samodzielny Publiczny Zaklad Opieki Zdrowotnej, Kielce
Velindre Cancer Centre, Cardiff
Weston Park Hospital, Sheffield
Gartnavel General Hospital, Glasgow
Royal Marsden Hospital (Chelsea), London
University College London Hospital, London
Royal Marsden Hospital (Sutton), London
Lead Sponsor
Eli Lilly and Company
INDUSTRY
Loxo Oncology, Inc.
INDUSTRY